Man breaks out in pustules in never-before-seen reaction to £5 erectile dysfunction drug sold on high street
The 40-year-old developed pustules - small bumps on the skin containing fluid or pus - covering his chest, face and thighs after taking tadalafil, sold as Cialis in the UK. (Source: the Mail online | Health)
Source: the Mail online | Health - February 9, 2024 Category: Consumer Health News Source Type: news

Viagra, Cialis May Help Reduce Alzheimer's Risk
THURSDAY, Feb. 8, 2023 -- Could drugs that give a boost to men ' s sexual performance help them stave off Alzheimer ' s disease? That ' s the main finding from a study suggesting that erectile dysfunction meds like Cialis, Levitra and Viagra might lower... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 8, 2024 Category: General Medicine Source Type: news

More Data Show ED Meds May Affect Alzheimer's Risk More Data Show ED Meds May Affect Alzheimer's Risk
Men with newly diagnosed erectile dysfunction who were prescribed drugs like sildenafil or tadalafil were 18% less likely to develop AD at 5-years follow-up, new research shows.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - February 7, 2024 Category: Endocrinology Tags: Neurology & Neurosurgery Source Type: news

Today The World Issues Voluntary Nationwide Recall of All Lots of Sustain and Schwinnng brand Dietary Supplement Capsules Due to the Presence of Undeclared Tadalafil and Nortadalafil
“Today The World” is voluntarily recalling two lots of Sustain herbal dietary supplement capsules and one lot of Schwinnng capsules to the consumer level. FDA analysis has found the products to contain undeclared Tadalafil and Nortadalafil (structurally similar to Tadalafil). Tadalafil and Norta dala (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 5, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Today The World Issues Voluntary Nationwide Recall of All Lots of Arize Herbal Dietary Supplement Capsules Due to the Presence of Undeclared Nortadalafil
“Today The World” is voluntarily recalling one lot of Arize Herbal Dietary Supplement capsules to the consumer level. FDA analysis has found the products to contain undeclared Nortadalafil (structurally similar to Tadalafil). Nortadalafil is an active drug ingredient known for treatment of male ere (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 5, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Viagra, Cialis Plus a Heart Med Could Be a Dangerous Combo
MONDAY, Jan. 15, 2024 -- Taking nitrates for heart problems alongside erectile dysfunction drugs like Viagra or Cialis could be a prescription for trouble, a new study warns. Men who combine the two types of medications have a higher risk of death... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 15, 2024 Category: General Medicine Source Type: news

5 Common Myths About Erectile Dysfunction
There’s a lot of misinformation about erectile dysfunction — a recurring inability to get an erection or sustain one during sex. Bad information, though, could lead men to wrongly assume that it’s a condition they must live with or that it requires expensive treatment. Here are 5 common myths…#myth2 #hims #himscom #learn #viagra #cialis (Source: Reuters: Health)
Source: Reuters: Health - October 24, 2023 Category: Consumer Health News Source Type: news

Forget Viagra! Men can now get another erection drug without needing a prescription
Boots is now selling Cialis without the need for a prescription. It follows a rule change earlier this year to reclassify the impotence drug, in a move hailed as 'good news for men's health'. (Source: the Mail online | Health)
Source: the Mail online | Health - June 6, 2023 Category: Consumer Health News Source Type: news

Janssen Submits New Drug Application to U.S. FDA Seeking Approval of Investigational Single Tablet Combination Therapy of Macitentan and Tadalafil for Treatment of Patients with Pulmonary Arterial Hypertension (PAH)
This is the first and only single tablet combination therapy application to be submitted for review in the U.S. for this rare, progressive disease If approved, Janssen’s comprehensive PAH portfolio has the potential to cover all... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - May 30, 2023 Category: Drugs & Pharmacology Source Type: news

Janssen Submits New Drug Application to U.S. FDA Seeking Approval of Investigational Single Tablet Combination Therapy of Macitentan and Tadalafil for Treatment of Patients with Pulmonary Arterial Hypertension (PAH)
RARITAN, NJ, May 30, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of an investigational single tablet combination therapy of macitentan 10mg and tadalafil 40mg (M/T STCT) for the long-term treatment of pulmonary arterial hypertension (PAH, World Health Organization [WHO] Group 1) in adult patients with WHO functional class (FC) II-III.[1] The application is based on positive data from the Phase 3 A DUE study, which met its primary endpoint and demonstrated that M/T STCT si...
Source: Johnson and Johnson - May 30, 2023 Category: Pharmaceuticals Source Type: news

Gear Isle Issues Voluntary Nationwide Recall of Pro Power Knight Plus, NUX Male Enhancement and DYNAMITE SUPER Capsules Due to the Presence of Sildenafil and Tadalafil
West Sacramento, CA, Gear Isle is voluntarily recalling the following products listed in the table below to the consumer level. FDA analysis has found the products to be tainted with sildenafil and tadalafil. Sildenafil and tadalafil are ingredients known as Phosphodiesterase Inhibitors (PDE-5) inhi (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 26, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Johnson & Johnson Reports Q1 2023 Results
New Brunswick, N.J. (April 18, 2023) – Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2023. “Our first quarter results demonstrate strong performance across all three segments of our business and reflect the dedication of Johnson & Johnson colleagues around the world,” said Joaquin Duato, Chairman of the Board and Chief Executive Officer. “With this momentum, I look forward to the remainder of the year, one filled with exciting catalysts that will create both near- and long-term value for patients and all of our stakeholders.”OVERALL FINANCIAL RESULTSQ1($ in Millions, except EPS)2...
Source: Johnson and Johnson - April 18, 2023 Category: Pharmaceuticals Tags: Financial Source Type: news

Fixed-Dose Combo Pill for PAH Promises Accelerated Benefit: A DUE Fixed-Dose Combo Pill for PAH Promises Accelerated Benefit: A DUE
According to a randomized trial, macitentan and tadalafil are safe and effective in a fixed-dose combination even as first-line therapy. The results of the three-arm study were presented at ACC 2023.MDedge News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 10, 2023 Category: Cardiology Tags: Cardiology News Source Type: news

Late-Breaking Phase 3 A DUE Data Show Investigational Single Tablet Combination Therapy of Macitentan and Tadalafil Significantly Improves Pulmonary Hemodynamics versus Monotherapy in Patients with Pulmonary Arterial Hypertension (PAH)
RARITAN, NJ, March 6, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the Phase 3 A DUE study (NCT03904693), which showed an investigational once-daily, single tablet combination therapy, also known as fixed dose combination, of macitentan 10 mg and tadalafil 40 mg (M/T STCT), significantly improved pulmonary hemodynamics (blood flow through pulmonary blood vessels) versus macitentan and tadalafil monotherapies in pulmonary arterial hypertension (PAH) patients with World Health Organization (WHO) functional class (FC) II or III.[1] The data were presented today as a Late-...
Source: Johnson and Johnson - March 6, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news

Volt Candy Issues Voluntary Nationwide Recall of PrimeZen Black 6000 Capsules Due to Presence of Sildenafil and Tadalafil
Pomona, California, Volt Candy is voluntarily recalling one lot of PrimeZen Black 6000, 2000 mg capsule, to the consumer level. FDA analysis has found PrimeZen Black 6000 capsules to be tainted with sildenafil& tadalafil. Sildenafil and tadalafil are phosphodiesterase (PDE-5) inhibitors found in FD (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 14, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news